Boston Trust Walden’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-204,840
Closed -$10.2M 383
2019
Q1
$10.2M Sell
204,840
-229,412
-53% -$10.3M 0.14% 188
2018
Q4
$15.7M Sell
434,252
-160,388
-27% -$6.7M 0.25% 116
2018
Q3
$30.3M Sell
594,640
-23,920
-4% -$1.06M 0.42% 70
2018
Q2
$22.9M Buy
618,560
+68,444
+12% +$2.61M 0.34% 94
2018
Q1
$20.8M Sell
550,116
-32,004
-5% -$1.13M 0.32% 99
2017
Q4
$18.9M Sell
582,120
-11,452
-2% -$364K 0.28% 114
2017
Q3
$17.9M Buy
593,572
+109,540
+23% +$3.25M 0.28% 112
2017
Q2
$14.2M Sell
484,032
-8,532
-2% -$233K 0.23% 132
2017
Q1
$12.5M Sell
492,564
-52,968
-10% -$1.37M 0.2% 160
2016
Q4
$14M Sell
545,532
-23,040
-4% -$605K 0.22% 156
2016
Q3
$15.6M Sell
568,572
-2,324
-0.4% -$63.8K 0.26% 141
2016
Q2
$16.1M Sell
570,896
-3,452
-0.6% -$88.7K 0.27% 136
2016
Q1
$13.6M Buy
574,348
+185,700
+48% +$4.09M 0.24% 159
2015
Q4
$8.74M Sell
388,648
-158,612
-29% -$3.62M 0.16% 184
2015
Q3
$12.7M Sell
547,260
-24,068
-4% -$604K 0.21% 173
2015
Q2
$14.1M Sell
571,328
-23,516
-4% -$587K 0.21% 165
2015
Q1
$14.9M Sell
594,844
-117,872
-17% -$2.8M 0.22% 159
2014
Q4
$16.5M Sell
712,716
-32,740
-4% -$749K 0.25% 158
2014
Q3
$17.4M Sell
745,456
-32,732
-4% -$767K 0.27% 148
2014
Q2
$18M Buy
778,188
+11,664
+2% +$258K 0.26% 151
2014
Q1
$16.4M Sell
766,524
-21,960
-3% -$494K 0.24% 155
2013
Q4
$18.7M Sell
788,484
-900,856
-53% -$19.5M 0.27% 144
2013
Q3
$33.8M Sell
1,689,340
-22,864
-1% -$434K 0.52% 86
2013
Q2
$29.6M Buy
+1,712,204
New +$28.4M 0.48% 94

Other funds holding TECH

Boston Trust Walden's TECH Position: Q2 2019 in Review

Boston Trust Walden sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 204,840 shares — an estimated $10.2M sold.

Boston Trust Walden first reported a position in TECH in Q2 2013 and held it in 24 quarters. The position peaked at $33.8M in Q3 2013. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

  • Boston Trust Walden reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
  • Boston Trust Walden sold 204,840 Bio-Techne shares in Q2 2019, an estimated $10.2M.
  • Boston Trust Walden first reported a position in Bio-Techne in Q2 2013 and held it in 24 quarters.
  • Boston Trust Walden's Bio-Techne position peaked at $33.8M in Q3 2013.
  • 369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on Boston Trust Walden's 13F filing for Q2 2019, filed 25 Jul 2019.